Skip to main content
SpringerLink
Log in

Pharmacological options for maintenance treatment of opioid dependence include opioid agonists and antagonists

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

References

  1. Tetrault JM, Fiellin DA. Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals. Drugs 2012; 72 (2): 217–28

    Article  PubMed  CAS  Google Scholar 

  2. World Health Organization. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva: WHO Press, 2009

    Google Scholar 

  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: fourth edition. DSM-IV. Washington, DC: American Psychiatric Association, 1994

    Google Scholar 

  4. Hallinan R, Byrne A, Agho K, et al. Hypogonadism in men receiving methadone and buprenorphine maintenance treatment. Int J Androl 2009; 32 (2): 131–9

    Article  PubMed  CAS  Google Scholar 

  5. Kim TW, Alford DP, Malabanan A, et al. Low bone density in patients receiving methadone maintenance treatment. Drug Alcohol Depend 2006; 85 (3): 258–62

    Article  PubMed  CAS  Google Scholar 

  6. Krantz MJ, Martin J, Stimmel B, et al. QTc interval screening in methadone treatment. Ann Intern Med 2009; 150 (6): 387–95

    Article  PubMed  Google Scholar 

  7. Gourevitch MN. First do no harm… reduction? Ann Intern Med 2009; 150 (6): 417–8

    Article  PubMed  Google Scholar 

  8. Anchersen K, Clausen T, Gossop M, et al. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study. Addiction 2009; 104 (6): 993–9

    Article  PubMed  Google Scholar 

  9. Dolophine® hydrochloride (methadone hydrochloride tablets, USP) 5 mg, 10 mg: US prescribing information. Columbus (OH): Roxane Laboratories, Inc., 2006 Oct

  10. Reynaud M, Petit G, Potard D, et al. Six deaths linked to concomitant use of buprenorphine and benzodiazepines. Addiction 1998; 93 (9): 1385–92

    Article  PubMed  CAS  Google Scholar 

  11. Deamer RL, Wilson DR, Clark DS, et al. Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM). J Addict Dis 2001; 20 (4): 7–14

    Article  PubMed  CAS  Google Scholar 

  12. Minozzi S, Amato L, Vecchi S, et al. Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database of Syst Rev 2011; (4): CD001333

  13. Tetrault JM, Tate JP, McGinnis KA, et al. Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone. Alcohol Clin Exp Res 2012 Feb; 36 (2): 318–24

    Article  PubMed  CAS  Google Scholar 

  14. Vivitrol® (naltrexone for extended-release injectable suspension) 380 mg/vial: US prescribinginformation. Waltham(MA): Alkermes, Inc., 2010 Oct

  15. Ling W, Casadonte P, Bigelow G, et al. Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial. JAMA 2010; 304 (14): 1576–83

    Article  PubMed  CAS  Google Scholar 

  16. Ferri M, Davoli M, Perucci CA. Heroin maintenance for chronic heroin-dependent individuals. Cochrane Database Syst Rev 2010; (8): CD003410

  17. Ward J, Rosenbaum C, Hernon C, et al. Herbal medicines for the management of opioid addiction: safe and effective alternatives to conventional pharmacotherapy? CNS Drugs 2011; 25 (12): 999–1007

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pharmacological options for maintenance treatment of opioid dependence include opioid agonists and antagonists. Drugs Ther Perspect 28, 11–14 (2012). https://doi.org/10.1007/BF03262113

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03262113

Search

Navigation